home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,352 rows where filing_year = 2021 and issue_code = "MED" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • third_quarter 344
  • second_quarter 342
  • first_quarter 334
  • fourth_quarter 332

issue_code 1

  • MED · 1,352 ✖

filing_year 1

  • 2021 · 1,352 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2591388 FRANCIS EDWARD & CRONIN, INC. d3045b15-a87a-4806-8280-1625a202d080 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 CURE ALZHEIMER'S FUND 2021 first_quarter MED Issues and legislation related to Alzheimer's disease research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 20000   0 0 2021-04-01T09:22:17.623000-04:00
2591395 FRANCIS EDWARD & CRONIN, INC. 35c2e6cb-2aa7-46c7-a1e5-de709afee504 Q1 FRANCIS EDWARD & CRONIN, INC. 311314 PATH DECISION SUPPORT SOFTWARE, LLC 2021 first_quarter MED Issues and legislation related to diabetes treatment and diagnosis HOUSE OF REPRESENTATIVES,Indian Health Service,Natl Institutes of Health (NIH),SENATE     0 0 2021-04-01T09:30:19.807000-04:00
2591471 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 98ca624f-7d5e-43a0-a3c1-b8009745a4f3 Q1 RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 400361684 PPLA 2021 first_quarter MED Pharmaceutical Labeling Food & Drug Administration (FDA) 18700   0 0 2021-04-01T14:16:44.343000-04:00
2591533 MILLER STRATEGIES, LLC 2edf49dd-126a-4ed5-a40d-cacff7c3b7c1 1T MILLER STRATEGIES, LLC 401104313 VIVEBIO SCIENTIFIC, LLC 2021 first_quarter MED Issues related to federal government approval of medical devices.       0 1 2021-04-01T17:58:15.023000-04:00
2591642 THE HARRIS FIRM 08961df2-0f27-4647-be9d-2e2d53eb6235 Q1 THE HARRIS FIRM 68376 HOLISTIC INDUSTRIES INC. 2021 first_quarter MED Issues pertaining to cannabis CSA scheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-02T13:50:09.800000-04:00
2591715 MARSHALL BRACHMAN 200704e2-cefd-4271-87d3-f895631b71ed Q1 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2021 first_quarter MED support funding for medical research programs HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2021-04-02T16:54:34.247000-04:00
2591783 THE FEDERAL GROUP, INC. 33a9289e-e473-4987-852e-ab1ec5c50884 Q1 THE FEDERAL GROUP, INC. 51104 ASSOCIATION OF CLINICAL RESEARCH PROFESSIONALS 2021 first_quarter MED Issues relating to clinical research Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2021-04-02T23:34:01.107000-04:00
2591817 NATURAL RESOURCE RESULTS LLC dbdf5989-3dc2-45e2-979d-ed2de8d59d77 Q1 NATURAL RESOURCE RESULTS LLC 321555 SHINE MEDICAL TECHNOLOGIES 2021 first_quarter MED Support funding at NNSA for Moly-99 domestic production facility construction. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-03T13:12:22.663000-04:00
2591920 LIVE OAK STRATEGIES 02c0da91-6b0e-41dc-b87a-f32d40a7503a Q1 LIVE OAK STRATEGIES 401105683 X. LABS 2021 first_quarter MED Issues related to public safety and healthcare technologies HOUSE OF REPRESENTATIVES,SENATE,White House Office 30000   0 0 2021-04-05T10:45:34.653000-04:00
2592047 RAY C CULVER III 58df3616-ad0a-487b-88ac-976ac09aad9c Q1 RAY C CULVER III 11468 ARKANSAS CHILDREN'S HOSPITAL 2021 first_quarter MED FY2022 Agricultural Appropriations bill funding for USDA ARS human nutrition research centers HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2021-04-05T15:21:50.513000-04:00
2592773 MARSHFIELD CLINIC HEALTH SYSTEM 35669c8c-7d33-4339-a0e4-f49646cee9a3 Q1 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2021 first_quarter MED COVID-19, agricultural occupational health, NIOSH Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2021-04-08T13:25:52.390000-04:00
2593150 DNV USA INC. 9b9d1dc2-56e6-479d-9738-94d3c15d34cb Q1 DNV USA INC. 400488400 DNV USA, INC. 2021 first_quarter MED Infection prevention, mitigation, and response for cruise ships. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Coast Guard (USCG)   40000 0 0 2021-04-10T22:58:00.487000-04:00
2593294 DQB INTERNATIONAL 606d2710-68fd-4efb-be01-89ffeadee063 Q1 DQB INTERNATIONAL 291834 TEXAS BIOMEDICAL RESEARCH INSTITUTE 2021 first_quarter MED FY 2022 Labor, HHS Appropriations Bill HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-04-12T11:23:04.897000-04:00
2593359 MCDERMOTT+ LLC 317042e3-1abb-4588-bf15-d35923cb55b0 Q1 MCDERMOTT+ LLC 401103287 COALITION FOR 21ST CENTURY MEDICINE 2021 first_quarter MED Issues concerning regulation of laboratory-developed tests. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2021-04-12T12:15:50.700000-04:00
2593413 BEN BARNES GROUP LP 9303938f-42dd-4808-b1a6-aed35334e4fe Q1 BEN BARNES GROUP LP 5415 ENVIGO RMS LLC 2021 first_quarter MED Medical/Disease Research HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2021-04-12T13:30:41.130000-04:00
2593522 THE PRENDA GROUP LLC 2ac02d79-16ab-4bba-9159-e3a34bde1ee4 Q1 THE PRENDA GROUP LLC 401104543 UV-CONCEPTS 2021 first_quarter MED Emergency response to COVID-19 Pandemic. Assistance to Hospitals / First Responders / Medical facilities etc. for patients, visitors, and healthcare workers. ULTRAVIOLET LIGHT ENCLOSURE TECHNOLOGY FOR BROAD APPLICATIONS IN HEALTHCARE AND NON-HEALTHCARE SECTORS. Monitoring COVID-19 Stimulus Packages and appropriations. Coronavirus Response and Relief H.R. 1319 HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-04-12T15:31:00-04:00
2593703 MOLNLYCKE HEALTH CARE US, LLC 2084ac44-cd72-4c53-a100-54cca90fee90 Q1 MOLNLYCKE HEALTH CARE US, LLC 401104898 MOLNLYCKE HEALTH CARE US, LLC 2021 first_quarter MED Personal Protective Equipment and Medical Research Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2021-04-12T18:23:43.250000-04:00
2593783 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 13198801-55b5-4c72-8602-87e5cf3b905e Q1 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 314055 THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 2021 first_quarter MED Support for the National Institutes of Health; Support for the National Eye Institute; Support for medical research activities at the Department of Defense HOUSE OF REPRESENTATIVES,SENATE   66489 0 0 2021-04-13T08:40:01.637000-04:00
2594306 O'NEILL AND ASSOCIATES 9198b70e-6485-43bc-abba-010a1c5df4e0 Q1 O'NEILL AND ASSOCIATES 73134 POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) 2021 first_quarter MED healthcare, medical HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2021-04-13T14:38:21.353000-04:00
2594324 O'NEILL AND ASSOCIATES c16f0ddd-71d2-4580-9bf1-099957cabce8 Q1 O'NEILL AND ASSOCIATES 73134 ANALOGIC 2021 first_quarter MED medical technology HOUSE OF REPRESENTATIVES,SENATE 14750   0 0 2021-04-13T14:51:41.370000-04:00
2594552 TODD STRATEGY GROUP a3b6f88b-774c-4f52-b9d2-7af3486fa27a Q1 TODD STRATEGY GROUP 401103321 ORGANIZE.ORG 2021 first_quarter MED Organ procurement policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 30000   0 0 2021-04-13T17:04:16.387000-04:00
2594577 INFECTIOUS DISEASES SOCIETY OF AMERICA 5142dc4f-b3e2-4cfd-a2bb-1ae7317bbaf0 Q1 INFECTIOUS DISEASES SOCIETY OF AMERICA 54836 INFECTIOUS DISEASES SOCIETY OF AMERICA 2021 first_quarter MED Antimicrobial resistance research, infectious disease product R&D regulatory science, unnecessary regulatory burdens placed on medical research; laboratory developed tests; comparative effectiveness research; support for evidence-based decision making; point-of-care diagnostic tests; and organ transplant policies to allow HIV+ to HIV+ organ transplants. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   75000 0 0 2021-04-13T17:21:32.727000-04:00
2594690 THE CJR GROUP, INC. f5d363d4-3f2b-443e-819d-04160b0f082f Q1 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2021 first_quarter MED Issues related to COVID-19 and funding for hospitals HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-13T20:24:08.317000-04:00
2594939 FEDERAL SOLUTIONS, LLC a2f88783-e055-496e-9a34-0abf9156f686 Q1 FEDERAL SOLUTIONS, LLC 311371 MISSISSIPPI STATE UNIVERSITY 2021 first_quarter MED Labor/HHS/Education Appropriations: Provisions relating to disease research Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE 50000   0 0 2021-04-14T11:31:24.177000-04:00
2595226 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) f2e5d50c-0fe5-48dc-95e7-fab756f8794d Q1 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 401103161 UNIVERSITY OF MARYLAND, BALTIMORE (UMB) 2021 first_quarter MED NONE HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2021-04-14T13:44:24.407000-04:00
2595474 STANFORD UNIVERSITY 12c1484d-73af-4e14-a9f5-718e4ec7773d Q1 STANFORD UNIVERSITY 36492 STANFORD UNIVERSITY 2021 first_quarter MED H.R. 1319 American Rescue Plan Act of 2021 H.R.708; S168 Temporary Reciprocity to Ensure Access to Treatment Act Health Professions programs Energy, Dept of,Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS)   90000 0 0 2021-04-14T16:06:00.697000-04:00
2595583 WARD AND SMITH, P.A. bc593f4e-8372-4d89-8c31-fa624b9cf72e 1T WARD AND SMITH, P.A. 44674 MED-EL CORPORATION 2021 first_quarter MED Fair bidding process for Defense contracts regarding cochlear implants and medical technology. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2021-04-14T16:55:32.220000-04:00
2595779 REPUBLIC CONSULTING, LLC 58fedfd2-cdc3-47be-b7cf-2e2b95b60a1f Q1 REPUBLIC CONSULTING, LLC 401016871 IQVIA 2021 first_quarter MED Monitored health Data Policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-15T08:39:42.810000-04:00
2595995 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 3a6ea7c3-d254-46b6-9a14-0bc3698a8105 Q1 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 52105 AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS 2021 first_quarter MED Supporting the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is a competitive grant program that funds research pertaining to extremity war injuries. HOUSE OF REPRESENTATIVES,SENATE   248040 0 0 2021-04-15T11:09:43.300000-04:00
2596007 THE CONAFAY GROUP, LLC b21125cb-579d-42a7-a4a2-055a5d3ad315 Q1 THE CONAFAY GROUP, LLC 401004840 HAWAII BIOTECH, INC. 2021 first_quarter MED seek support for medical countermeasures. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-04-15T11:19:47.157000-04:00
2596034 THE CONAFAY GROUP, LLC 08f0d849-e83a-4d74-9b1f-004f4e579ed4 Q1 THE CONAFAY GROUP, LLC 401004840 ACADIA PHARMACEUTICALS INC. 2021 first_quarter MED Pharmaceutical Research   10000   0 0 2021-04-15T11:33:52.357000-04:00
2596056 THE CONAFAY GROUP, LLC 6b91f2d1-f77a-4962-b592-c36f164cbd10 Q1 THE CONAFAY GROUP, LLC 401004840 ROIVANT SCIENCES, INC. 2021 first_quarter MED Support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-04-15T11:45:59.840000-04:00
2596084 THE CONAFAY GROUP, LLC 5bb2f0ca-07e0-4a80-8c69-cb8b505f1487 Q1 THE CONAFAY GROUP, LLC 401004840 EMERJA, INC. (FORMERLY KNOWN AS WHEEL BIOLOGY, INC.) 2021 first_quarter MED Seek support for research and development funding.       0 0 2021-04-15T12:06:09.323000-04:00
2596107 THE CONAFAY GROUP, LLC bc76eed4-cfc0-45c3-bda4-0361923bf32c Q1 THE CONAFAY GROUP, LLC 401004840 LYSOVANT SCIENCES INC. 2021 first_quarter MED support medical disease research.       0 0 2021-04-15T12:14:14.247000-04:00
2596152 THE CONAFAY GROUP, LLC d87a81f7-5c87-4725-8c41-a3a2a1ba6878 Q1 THE CONAFAY GROUP, LLC 401004840 CENTIVAX 2021 first_quarter MED support for medical/disease research. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-04-15T12:24:22.920000-04:00
2596179 THE CONAFAY GROUP, LLC c9fccb6b-f962-4c59-863c-6e70ff831cf1 Q1 THE CONAFAY GROUP, LLC 401004840 ATEA PHARMACEUTICALS, INC. 2021 first_quarter MED Support for medical/disease research.   30000   0 0 2021-04-15T12:35:30.390000-04:00
2596188 THE CONAFAY GROUP, LLC da2ec1d0-22fc-48cd-8234-850c77718653 Q1 THE CONAFAY GROUP, LLC 401004840 CURIA GLOBAL, INC. (FORMERLY KNOWN AS ALBANY MOLECULAR RESEARCH, INC.) 2021 first_quarter MED Federal support to advance medical research Health & Human Services, Dept of (HHS) 10000   0 0 2021-04-15T12:38:32.707000-04:00
2596235 THE CONAFAY GROUP, LLC a3a78771-c692-47de-aa62-5ab9053e6529 Q1 THE CONAFAY GROUP, LLC 401004840 LUNGPACER MEDICAL USA, INC 2021 first_quarter MED seek support for research and development funding. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS)     0 0 2021-04-15T13:19:56.707000-04:00
2596251 RYAN COSTELLO STRATEGIES f3e38128-0e6e-4ff8-82f4-81ec0642a8dc Q1 RYAN COSTELLO STRATEGIES 401105569 CARDIOL THERAPEUTICS 2021 first_quarter MED No specific lobbying issues this quarter, determining applicable research grant opportunities HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2021-04-15T13:36:01.103000-04:00
2596339 MICHAEL N. MCCARTY LAW OFFICE PLLC 7faec0a4-7ff2-4c47-bfc5-e71ea29c93c2 Q1 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2021 first_quarter MED Support S. 236, the Tracking COVID-19 Variants Act; support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; monitor legislative efforts to regulated laboratory-developed tests (LDTs); support initiatives to improve COVID-19 testing supply chains. HOUSE OF REPRESENTATIVES,SENATE,White House Office 10000   0 0 2021-04-15T14:17:26.553000-04:00
2596390 AMERICAN COLLEGE OF CLINICAL PHARMACY 6471f83a-97bc-4294-b1b9-1a5a742d00ca Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2021 first_quarter MED Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2021-04-15T14:34:43.143000-04:00
2596426 STRATEGIC MARKETING INNOVATIONS c7483284-0e71-45c4-9029-5c7406c1cd2b Q1 STRATEGIC MARKETING INNOVATIONS 60550 IGM BIOSCIENCES, INC. 2021 first_quarter MED Antibody therapy for COVID-19 HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-04-15T14:58:54.787000-04:00
2596430 STRATEGIC MARKETING INNOVATIONS 379ad285-4834-4c5d-b6c3-0a1b5ccdbbf1 Q1 STRATEGIC MARKETING INNOVATIONS 60550 INTRIVO DIAGNOSTICS 2021 first_quarter MED Antigen Testing Technology HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-04-15T15:01:56.417000-04:00
2596578 IPOLICY SOLUTIONS 0d69ea1e-417d-4eac-811c-52b6716fbeb1 Q1 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2021 first_quarter MED No bill number, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage No bill number, Verified Innovative Testing in American Laboratories (VITAL) Act Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 42000   0 0 2021-04-15T16:12:45.657000-04:00
2596587 IPOLICY SOLUTIONS 2ac61c8c-cbbf-4663-a04d-17691e1621f9 Q1 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2021 first_quarter MED Emergency Use Authorization for COVID-19 Diagnostics S.236 - Tracking COVID-19 Variants Act CDC Advanced Molecular Detection Program Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 75000   0 0 2021-04-15T16:23:47.607000-04:00
2596609 IPOLICY SOLUTIONS 550197d3-6fd4-4e31-a2b5-0f025aefafdb Q1 IPOLICY SOLUTIONS 401105127 EVERLY HEALTH (FORMERLY KNOWN AS EVERLYWELL) 2021 first_quarter MED Emergency Use Authorization for at home test collection HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2021-04-15T16:32:52.317000-04:00
2596672 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 48c32028-ee05-482f-8820-3818f45f78e1 Q1 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 312496 CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 2021 first_quarter MED CHGME, NIH, PACT ACT, Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   30890 0 0 2021-04-15T17:01:11.273000-04:00
2596809 FAEGRE DRINKER BIDDLE & REATH LLP 6c20741b-dc92-4e86-a1a0-afd806c39cf8 Q1 FAEGRE DRINKER BIDDLE & REATH LLP 12631 AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE 2021 first_quarter MED Public Health Programs for Infectious and Tropical Disease; Tracking COVID 19 Variants Act; National Defense Authorization Act provisions related to malaria research. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-15T19:35:59.060000-04:00
2596885 MICHIGAN TECHNOLOGICAL UNIVERSITY acb94e50-cb27-417c-ab5e-50de6f2cb4ec Q1 MICHIGAN TECHNOLOGICAL UNIVERSITY 25181 MICHIGAN TECHNOLOGICAL UNIVERSITY 2021 first_quarter MED Discussed issues of interest related to higher education for the COVID-19 pandemic. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2021-04-16T07:39:22.833000-04:00
2596946 AMERICAN PHYSICAL THERAPY ASSOCIATION 35af9a1a-1510-4135-9220-445df6ec85df Q1 AMERICAN PHYSICAL THERAPY ASSOCIATION 3093 AMERICAN PHYSICAL THERAPY ASSOCIATION 2021 first_quarter MED NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding PT role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) Falls and Falls Prevention Outpatient Therapy Modernization and Stabilization Act Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office   240544 0 0 2021-04-16T09:05:40.763000-04:00
2597618 AMERICAN PHARMACISTS ASSOCIATION 50dda657-e4b2-4946-b517-6ff1bc83e7c9 Q1 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2021 first_quarter MED H.R.747 -- Access to Technology and Equipment for Same-day Tests Act     35000 0 0 2021-04-16T12:33:19.073000-04:00
2597980 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 803df0bd-3390-4c71-a415-885f1ba15f16 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 WOMEN FIRST RESEARCH COALITION 2021 first_quarter MED Increasing women's health research HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2021-04-16T14:08:53.837000-04:00
2598038 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. da6f55e3-0e1a-4271-8f20-66486da7285b Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 DEFENSE HEALTH RESEARCH CONSORTIUM 2021 first_quarter MED FY22 Defense Appropriations Act, Defense Health Research Programs HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-04-16T14:26:16.947000-04:00
2598048 EFB ADVOCACY, LLC 0eb23fbb-6c8f-4aed-a68c-000038a2af87 Q1 EFB ADVOCACY, LLC 401104430 UNITED FOR MEDICAL RESEARCH 2021 first_quarter MED Funding Issues Related to the National Institutes of Health HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-16T14:30:20.947000-04:00
2598086 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. ee974e53-72c9-463f-9308-4ac0b52593f6 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 PANCREATIC CANCER ACTION NETWORK (PANCAN) 2021 first_quarter MED cancer research at DoD and NIH FY 22 Defense Appropriations Act, Peer-Reviewed Pancreatic Cancer Research Program FY 22 Labor-HHS-Education Act, NIH research on pancreatic cancer HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2021-04-16T14:41:29.310000-04:00
2598112 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 955f6d03-f6f9-46b5-998d-16736bc3dc0b Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 FOUNDATION FOR PERIPHERAL NEUROPATHY 2021 first_quarter MED FY22 Defense Appropriations Act, DoD funding for peripheral neuropathy research HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-04-16T14:44:32.563000-04:00
2598197 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0fe03caf-fb8a-4c41-9f52-fb6d90992217 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 TUBEROUS SCLEROSIS ALLIANCE 2021 first_quarter MED FY22 Defense Appropriations Act, Tuberous Sclerosis Complex Research Program FY22 Labor-HHS-Appropriations Act, NIH and CDC research on tuberous sclerosis complex NIH research on tuberous sclerosis complex HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2021-04-16T15:05:01.157000-04:00
2598241 BUCHANAN INGERSOLL & ROONEY PC 6fd90043-a77d-4147-a492-cd218c0902e8 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 AMIVAS, LLC 2021 first_quarter MED FDA post-approval of malaria products Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-04-16T15:19:14.007000-04:00
2598250 MCHUGH LEMAY ASSOC., LLC efa813f3-32f4-4112-891b-031134d02075 Q1 MCHUGH LEMAY ASSOC., LLC 401105253 CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2021 first_quarter MED Issues related to COVID testing - no specific legislation. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-16T15:22:17.023000-04:00
2598255 COMPASS MANAGEMENT PARTNERS, INC. 997f391a-8150-42b1-8724-8b516d26f496 Q1 COMPASS MANAGEMENT PARTNERS, INC. 401105171 THE LIVING LEGACY FOUNDATION OF MARYLAND 2021 first_quarter MED Regulations impacting accountability requirements at organ procurement organizations; organ donation matters HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-04-16T15:23:18.310000-04:00
2598281 BUCHANAN INGERSOLL & ROONEY PC 33901d14-3e95-465d-a483-10b6d44c3d57 Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2021 first_quarter MED Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-16T15:31:24.800000-04:00
2598332 CLARK STREET ASSOCIATES 5f78a63d-a9f7-4277-a1b6-0b82b7d989f5 Q1 CLARK STREET ASSOCIATES 401105692 QORVO 2021 first_quarter MED Issues related to COVID testing - no specific legislation. Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office 190000   0 0 2021-04-16T15:43:41.130000-04:00
2598398 SIDLEY AUSTIN LLP c7d3cd31-8b01-4070-9642-a7fdb5ece4bf Q1 SIDLEY AUSTIN LLP 35230 CORD BLOOD ASSOCIATION 2021 first_quarter MED Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015. Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),White House Office 20000   0 0 2021-04-16T15:56:59.177000-04:00
2598451 NATIONAL ASSOCIATION OF SPINE SPECIALISTS eec188ab-5846-4fae-bab3-c912b8bf1965 Q1 NATIONAL ASSOCIATION OF SPINE SPECIALISTS 400395865 NATIONAL ASSOCIATION OF SPINE SPECIALISTS 2021 first_quarter MED Supporting the Peer-Reviewed Orthopaedic Research Program (PRORP). PRORP is acompetitive grant program that funds research pertaining to extremity war injuries. HOUSE OF REPRESENTATIVES,SENATE   63506 0 0 2021-04-16T16:09:14.757000-04:00
2598575 BLUEBIRD STRATEGIES bafa1a2d-6a27-46e5-a064-9dc7f60e739d Q1 BLUEBIRD STRATEGIES 401105447 MYOTONIC 2021 first_quarter MED Increasing funding for Myotonic Dystrophy research. Fiscal year 2020 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2021-04-16T16:44:44.413000-04:00
2598620 BLUEBIRD STRATEGIES d5de6104-fbf3-4fa6-911c-23c59dacbed7 Q1 BLUEBIRD STRATEGIES 401105447 MYRIAD GENETICS, INC. 2021 first_quarter MED Legislation to regulate clinical labs under CLIA and FDA. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-16T17:02:54.243000-04:00
2598953 HAWLEY LLC ce8bdefa-672e-47e6-be55-391281be6858 Q1 HAWLEY LLC 401105460 MLA ASSOCIATES ON BEHALF OF CLARK STREET ASSOCIATES LLC ON BEHALF OF QORVO 2021 first_quarter MED Issues related to pathogen for COVID 19 and other diseases testing. Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE 30000   0 0 2021-04-17T09:13:14.527000-04:00
2598994 FORBES-TATE 861753d3-7ae5-48e8-96a8-3227790c429c Q1 FORBES-TATE 400976792 AMGEN USA, INC. 2021 first_quarter MED Issues related to Biosimilars. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-17T10:05:03.157000-04:00
2599015 FORBES-TATE 25f1bd84-095b-49e4-8725-cd484aa89f12 Q1 FORBES-TATE 400976792 CALIFORNIA LIFE SCIENCES ASSOCIATION 2021 first_quarter MED Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2021-04-17T10:29:10.167000-04:00
2599223 DESIMONE CONSULTING, LLC 3de3dc87-c154-4d42-9564-7c81113d280f Q1 DESIMONE CONSULTING, LLC 400931695 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2021 first_quarter MED Issues related to access to medicines and other medical therapies, the development of new medical therapies, pharmaceutical supply chain and regulatory matters regarding the biopharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-17T13:18:59.457000-04:00
2599493 CAPITOL COUNSEL LLC cf222d3f-5d4e-4488-9169-69e26eb43612 Q1 CAPITOL COUNSEL LLC 313715 BLUE EARTH DIAGNOSTICS, INC. 2021 first_quarter MED To gain support for adequate Medicare reimbursement for diagnostic radiopharmaceuticals; Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-17T16:24:20.077000-04:00
2599500 CAPITOL COUNSEL LLC 2cd7ef58-319c-451b-8926-f14c507f2530 Q1 CAPITOL COUNSEL LLC 313715 EMD SERONO, INC. 2021 first_quarter MED Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-17T16:34:23.210000-04:00
2599508 CAPITOL COUNSEL LLC 0173986e-7b78-49f2-be67-362542e3660e Q1 CAPITOL COUNSEL LLC 313715 MASSACHUSETTS BIOTECHNOLOGY COUNCIL 2021 first_quarter MED Monitor health and tax legislation pertaining to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-17T16:38:24.670000-04:00
2599644 AMERICAN SOCIETY OF ADDICTION MEDICINE 6f8e6655-4c07-4ae0-b642-7c37a4276b5e Q1 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2021 first_quarter MED Submitted comments on the Interim Final Rule on the Implementation of the SUPPORT Act regarding dispensing and administering controlled substances for medication-assisted treatment Provided technical assistance on language in the Lessening Addiction by Enhancing Labeling Opioids Act so that any new label would not inappropriately refer to buprenorphine Discussions with Congressional offices regarding prescriber education, substance use disorder curricula grants, and opioid analgesics prescription limiation provisions in conjunction with the Comprehensive Addiction Recovery Act Supported and provided technical assistance regarding the re-introduction of the Medication Access and Trainng Expansion Act of 2021 (HR 2067) and supported its simultaneous passage with the Mainstreaming Addiction Treatment Act of 2021 (HR 1384) Suggested grant eligibility and Medicaid and Medicare related changes regarding provider reimbursement bump and substance use disorder coverage in conjunction with the possible reintroduction of the CARE Act of 2021. Supported passage of the Medicaid Reentry Act (HR 955/S 285) and its inclusion in the American Rescue Plan Discussion with ONDCP staff regarding drug policy priorities in 2021 Advocated for creation of a new safe harbor provision to the Federal Anti-Kickback Statute to protect the use of cash and cash-equivalent payments offered as part of contingency management in the treatment of substance use disorders Supported the Tele-Mental Health Improvement Act, which would require group health plans and insurers to cover mental health and addiction telehealth services during the COVID-19 public health emergency Advocated for increased FY 22 appropriations for HRSA's Mental Health and Substance Use Disorders Training Demonstration program, SAMHSA's expansion of practitioner education grant program, and HRSA's Substance Use Disorder (SUD) Workforce Loan Repayment Program, among other SUD workforce-related appropriation increases in conjunction with other coalitions Supprted the Quit … Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   90000 0 0 2021-04-18T07:09:07.443000-04:00
2599952 TIBER CREEK GROUP 0732acab-2111-470d-9553-5c6a5c264daa Q1 TIBER CREEK GROUP 20744 JAZZ PHARMACEUTICALS 2021 first_quarter MED Issues related to the FDA and S. 3032 - the FDA STATES Act, and Health and Human Services pertaining to CBD policies. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2021-04-18T16:51:37.873000-04:00
2599974 MARCHIBRODA GROUP, LLC 59833718-da19-40da-b856-c2db94b023b0 Q1 MARCHIBRODA GROUP, LLC 401105875 ALLIANCE FOR CELL THERAPY NOW 2021 first_quarter MED Advocacy for increased federal funding of clinical trials for cell-based therapies for COVID-19 and other serious, life-threatening conditions in both the American Rescue Act Plan of 2021 and FY 2022 appropriations legislation HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2021-04-18T17:28:47.103000-04:00
2599976 OGR 35c5ec0e-1b57-4561-93f6-a823c87631e3 Q1 OGR 48827 ATLAS SUPPLY LLC 2021 first_quarter MED Issues related to COVID-19 diagnostics technology. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2021-04-18T17:30:47.593000-04:00
2599979 OGR 32c04f62-4502-49f1-a430-cdf7b9a51713 Q1 OGR 48827 WEAVR HEALTH 2021 first_quarter MED COVID-19 serology issues   20000   0 0 2021-04-18T17:38:49.033000-04:00
2600054 OGR 7675276e-5d56-45bd-bb12-268110761dd7 Q1 OGR 48827 SMITHS GROUP PLC 2021 first_quarter MED Medical device technology related to the opioid epidemic and the COVID-19 pandemic. S.586, NOPAIN Act. Bureau of Reclamation,Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-18T18:43:05.943000-04:00
2600272 VAN SCOYOC ASSOCIATES 98fd49c1-92e4-4241-856d-927bece677c8 Q1 VAN SCOYOC ASSOCIATES 39837 AMERICAN ACADEMY OF ADDICTION PSYCHIATRY 2021 first_quarter MED Education and training for health practitioners who deliver medication s and treatment for individuals with Substance Abuse Disorders (SUDs) H.R.1384/S.445, Mainstreaming Addiction Treatment Act H.R. 2067, Medication Access and Training Expansion Act Health & Human Services, Dept of (HHS),Office of Natl Drug Control Policy (NDCP),Substance Abuse & Mental Health Services Administration (SAMHSA) 20000   0 0 2021-04-19T06:58:07.460000-04:00
2600327 VAN SCOYOC ASSOCIATES 05b4c65e-bc60-448f-80c2-3aebdb8d9686 Q1 VAN SCOYOC ASSOCIATES 39837 GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION 2021 first_quarter MED CDC, Infectious Diseases E-Cigarettes related issues NIMHD Research Endowment Revitalization Act, Entirety Public Law 117-2, American Rescue Plan of 2021, Higher Education research related issues; and SARS CoV2 issues Public Law 116-260, Consolidated Appropriations Act, FY2021, Higher Education research related issues; and SARS CoV2 issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-04-19T07:30:17.563000-04:00
2600334 VAN SCOYOC ASSOCIATES 49b92cf3-5043-4c72-a15f-7b627687f65c Q1 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF TOLEDO 2021 first_quarter MED Higher Education research related issues; and SARS-CoV2 issues, as follows: Implementation of Public Law 116-260, Consolidated Appropriations Act, 2021 Public Law 117-2, American Rescue Plan Act of 2021 HOUSE OF REPRESENTATIVES 20000   0 0 2021-04-19T07:32:18.473000-04:00
2600432 VAN SCOYOC ASSOCIATES 6f5399e8-37a6-4736-bc96-096129936c88 Q1 VAN SCOYOC ASSOCIATES 39837 HUMANIGEN, INC. 2021 first_quarter MED Therapeutics manufacturing related issues, as follows: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2022 Implementation of Public Law 116-260, Consolidated Appropriations Act, FY2022 HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-19T07:54:35.963000-04:00
2600509 MANATOS & MANATOS 6d1a890a-90b9-465f-97f6-e7282be83030 Q1 MANATOS & MANATOS 23634 BARBARA ANN KARMANOS CANCER INSTITUTE 2021 first_quarter MED PPS-exemption HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-04-19T08:43:53.487000-04:00
2600515 HACKENSACK MERIDIAN HEALTH fd43a031-73d7-4369-99e0-769984edfd22 Q1 HACKENSACK MERIDIAN HEALTH 401104109 HACKENSACK MERIDIAN HEALTH 2021 first_quarter MED National Institutes of Health funding Biosafety laboratories Support for the Center for Discovery and Innovation Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE   160000 0 0 2021-04-19T08:45:56.287000-04:00
2600699 NEOGENOMICS LABORATORIES 86d682af-717a-440f-82bc-17e18ef7b004 Q1 NEOGENOMICS LABORATORIES 401105014 NEOGENOMICS LABORATORIES 2021 first_quarter MED Verifying Accurate Leading-edge IVCT Development Act of 2020, S. 3404 HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2021-04-19T09:31:32.477000-04:00
2600767 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. eb932dc7-9546-4b37-aee6-e8e607f38856 Q1 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 401104196 OAK RIDGE ASSOCIATED UNIVERSITIES, INC. 2021 first_quarter MED FY21 Omnibus Appropriations Act Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2021-04-19T09:43:46.313000-04:00
2600932 MAGNET STRATEGY GROUP eed2ea86-2ea5-42db-b545-9b7efc79737e Q1 MAGNET STRATEGY GROUP 401104125 MEDICAGO INC. 2021 first_quarter MED MED HOUSE OF REPRESENTATIVES,SENATE     0 0 2021-04-19T10:09:19.747000-04:00
2601153 UNIVERSITY OF IOWA 6a5bed25-7edc-4377-b284-bc2514dda0d9 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2021 first_quarter MED Support for robust funding for federal agencies that fund medical and disease research Support for increased federal funding for research and response efforts in response to COVID-19 Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE   80000 0 0 2021-04-19T10:34:06.737000-04:00
2601250 WILLIAMS AND JENSEN, PLLC 8295e10b-b416-4303-957d-29a4385cce7b Q1 WILLIAMS AND JENSEN, PLLC 41454 GLOBAL DOWN SYNDROME FOUNDATION 2021 first_quarter MED Support for down syndrome research funding. Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2021-04-19T10:42:26.590000-04:00
2601700 THE CORMAC GROUP, LLC 147752c0-32f7-498e-89a0-b792c393de87 Q1 THE CORMAC GROUP, LLC 66773 KESSLER FOUNDATION 2021 first_quarter MED Appropriations, DOD, TBI Research, Veterans Issues Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-19T11:18:18.323000-04:00
2601964 WAKE FOREST UNIVERSITY HEALTH SCIENCES 4277ae08-a5ac-4cfc-8258-55d67b3bf3f4 Q1 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2021 first_quarter MED 340 (b) program guidelines; HRSA community project funding; "Research Investment to spark the Economy" (RISE) Act; "US Citizenship Act of 2021"; Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2021-04-19T11:36:36.693000-04:00
2601970 WILLIAMS AND JENSEN, PLLC 60c55de3-950f-4a68-a778-941237ac8b5b Q1 WILLIAMS AND JENSEN, PLLC 41454 ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) 2021 first_quarter MED Issues related to FDA regulation of medical devices, including the Critical Medical Infrastructure Right to Repair Act. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2021-04-19T11:37:39.060000-04:00
2601992 UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL fc46b70f-d542-420e-bcb3-f8e15706f72e Q1 UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 89235 UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2021 first_quarter MED Issues related to pandemic preparedness. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA)   35000 0 0 2021-04-19T11:37:42.720000-04:00
2602025 WILLIAMS AND JENSEN, PLLC c7e86ca3-68cb-48ca-9474-11509ea23aff Q1 WILLIAMS AND JENSEN, PLLC 41454 BIOBOT ANALYTICS 2021 first_quarter MED General education to advance policies that support wastewater based epidemiology and wastewater surveillance data analytic technology. Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319. Centers For Disease Control & Prevention (CDC),Environmental Protection Agency (EPA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2021-04-19T11:39:51.870000-04:00
2602040 VAN SCOYOC ASSOCIATES 7eaeb53d-b1b7-4d6c-9fd3-e6661b04902d Q1 VAN SCOYOC ASSOCIATES 39837 MEDICAL UNIVERSITY HOSPITAL AUTHORITY 2021 first_quarter MED Monitor Medical research and development related issues: National Institutes of Health and various institutes and bureaus thereof Health Resources Services Administration HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2021-04-19T11:41:56.480000-04:00
2602067 BROWNSTEIN HYATT FARBER SCHRECK, LLP 1be9dc0a-bb5c-4af4-8781-873b9e4f090f Q1 BROWNSTEIN HYATT FARBER SCHRECK, LLP 7257 ANTHEM, INC. 2021 first_quarter MED Issues related to the individual marketplace Health insurance tax and general tax issues Part D H.R.1319 - American Rescue Plan Act of 2021   50000   0 0 2021-04-19T11:43:01.387000-04:00
2602122 VAN SCOYOC ASSOCIATES d6959a96-b937-466a-a44f-7fbad0d236ba Q1 VAN SCOYOC ASSOCIATES 39837 ARUP LABORATORIES, INC. 2021 first_quarter MED Verifying Accurate Leading-edge IVCT Development (VALID) Act, Diagnostic Lab Testing COVID-19 Laboratory Testing related issues, as follows: Public Law 116-260, Consolidated Appropriations Act, 2021 Public Law 117-2, American Rescue Plan Act of 2021 American Jobs Plan Monitor Highly skilled visa related issues SENATE 30000   0 0 2021-04-19T11:48:14.947000-04:00
2602146 WILLIAMS AND JENSEN, PLLC a9dc1bf2-74ec-4503-a10b-0a9b30921a60 Q1 WILLIAMS AND JENSEN, PLLC 41454 SANOFI, U.S. 2021 first_quarter MED General education about FDA approval policies and NIH research activities. HOUSE OF REPRESENTATIVES,SENATE,White House Office 50000   0 0 2021-04-19T11:51:20.893000-04:00
2602185 WILLIAMS AND JENSEN, PLLC db81d619-f89a-476f-b2de-0b7232b00df5 Q1 WILLIAMS AND JENSEN, PLLC 41454 VERTEX PHARMACEUTICALS INCORPORATED 2021 first_quarter MED General education about FDA approval policies and NIH research activities. HOUSE OF REPRESENTATIVES,SENATE,White House Office 30000   0 0 2021-04-19T11:53:28.387000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2458.463ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API